Preliminary experiments reveal conolidine may inhibit particular ion channels, decreasing neuronal excitability and restricting soreness indicators. This system is particularly applicable in neuropathic soreness, wherever abnormal signaling causes persistent discomfort. Moreover, conolidine appears to impact G protein-coupled receptor (GPCR) pathways integral to discomfort perception.... https://irvingm379wtp0.wikicommunications.com/user